Stocks TelegraphStocks Telegraph
Stock Ideas

COEP Financial Statements and Analysis

PNK : COEP

Coeptis Therapeutics, Inc.

$0.31
0.0139+4.73%
At Close 4:00 PM
$10.80
10.49+3,405.84%
After-Market 04:00 PM

COEP FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

COEP Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q3Q2
revenue00000
cost of revenue431.304K250.211K250.211K250.309K250.309K
gross profit-431.304K-250.211K-250.211K-250.309K-250.309K
gross profit ratio00000
research and development expenses811.784K398.817K777.069K4.983M377.04K
general and administrative expenses1.08M2.174M1.895M2.816M3.218M
selling and marketing expenses05.00K1.626M12.412K300.00
selling general and administrative expenses1.08M2.179M1.895M2.828M3.218M
other expenses250.00K086.625K-38.601K0
operating expenses2.142M2.578M2.672M7.812M3.595M
cost and expenses2.142M2.828M2.922M7.812M3.595M
interest income00000
interest expense50.926K66.056K200.505K19.80K42.636K
depreciation and amortization278.229K250.211K250.211K250.309K250.309K
ebitda-1.50M-2.719M-2.551M-7.60M-3.345M
ebitda ratio00000
operating income-2.142M-2.828M-2.922M-7.831M-3.638M
operating income ratio00000
total other income expenses net312.875K-207.243K-79.005K1.571M525.00K
income before tax-1.829M-3.035M-3.001M-6.261M-3.113M
income before tax ratio00000
income tax expense00-1.00-18.801K42.636K
net income-1.829M-3.035M-3.001M-6.261M-3.113M
net income ratio00000
eps-0.046-0.081-0.084-0.23-0.14
eps diluted-0.046-0.081-0.084-0.23-0.14
weighted average shs out39.807M37.569M35.545M26.65M21.809M
weighted average shs out dil39.807M37.569M35.545M26.65M21.809M
Graph

COEP Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q3Q2
cash and cash equivalents
short term investments
cash and short term investments
net receivables
inventory
other current assets
total current assets
property plant equipment net
goodwill
intangible assets
goodwill and intangible assets
long term investments
tax assets
other non current assets
total non current assets
other assets
total assets
account payables
short term debt
tax payables
deferred revenue
other current liabilities
total current liabilities
long term debt
deferred revenue non current
deferred tax liabilities non current
other non current liabilities
total non current liabilities
other liabilities
capital lease obligations
total liabilities
preferred stock
common stock
retained earnings
accumulated other comprehensive income loss
other total stockholders equity
total stockholders equity
total equity
total liabilities and stockholders equity
minority interest
total investments
total debt
net debt
Graph

COEP Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-09-302023-06-302023-03-31
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q3Q2Q1
deferred income tax00-1.094M286.50K0
stock based compensation611.57K96.889K113.301K113.301K122.391K
change in working capital-29.017K86.873K181.425K209.04K195.054K
accounts receivables-82.50K0008.075K
inventory00000
accounts payables-84.746K-53.801K86.772K152.779K143.432K
other working capital55.729K140.674K94.653K56.261K43.547K
other non cash items1.982M1.316M4.852M351.00K5.616M
net cash provided by operating activities-1.418M-1.902M-1.958M-1.903M-1.684M
investments in property plant and equipment1.000000
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites0-100.00K350.00K-350.00K0
net cash used for investing activites0-100.00K350.00K-350.00K0
debt repayment-200.00K-1.063M-374.999K-349.585K0
common stock issued1.694M500.00K500.074K3.041M0
common stock repurchased00000
dividends paid00000
other financing activites50.00K500.00K-350.00K699.585K0
net cash used provided by financing activities1.944M1.563M-224.925K3.391M0
effect of forex changes on cash00000
net change in cash525.831K-439.89K-1.833M1.138M-1.684M
cash at end of period1.555M1.029M1.412M3.245M2.107M
cash at beginning of period1.029M1.469M3.245M2.107M3.791M
operating cashflow-1.418M-1.902M-1.958M-1.903M-1.684M
capital expenditure1.000000
free cash flow-1.418M-1.902M-1.958M-1.903M-1.684M
Graph

Frequently Asked Questions

How did Coeptis Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, COEP generated $0.00 in revenue last quarter, while its costs came in at $431.30K.

Last quarter, how much Gross Profit did Coeptis Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Coeptis Therapeutics, Inc. reported a -$431.30K Gross Profit for the quarter ended Jun 30, 2024.

Have COEP's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. COEP incurred $2.14M worth of Operating Expenses, while it generated -$2.14M worth of Operating Income.

How much Net Income has COEP posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Coeptis Therapeutics, Inc., the company generated -$1.83M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Coeptis Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Coeptis Therapeutics, Inc. as of the end of the last quarter was -.

What are COEP's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, COEP had Total Net Receivables of -.

In terms of Total Assets and Current Assets, where did Coeptis Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of COEP were -, while the Total Assets stand at -.

As of the last quarter, how much Total Debt did Coeptis Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of COEP's debt was - at the end of the last quarter.

What were COEP's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, COEP reported total liabilities of -.

How much did COEP's Working Capital change over the last quarter?

Working Capital Change for COEP was -$29.02K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

COEP generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. COEP generated -$1.42M of Cash from Operating Activities during its recently reported quarter.

What was COEP's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. COEP reported a $525.83K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph